SmartLipo MPX For Slimming

SmartLipo MPX uses the latest advancements in cosmetic surgery technology, which provide a safer, quicker and cost-effective method.

Pioneered in Europe, the SmartLipo MPX procedure is the first laser-assisted SmartLipo MPX procedure. SmartLipo MPX was approved by the FDA in November of 2006 and has quickly been labeled the cutting edge procedure in cosmetic surgery.

According to SmartLipo MPX ’s manufacturer, Cynosure, the SmartLipo MPX system has quickly become one of the most successful SmartLipo MPX procedures in the cosmetic surgery field for its use of cutting-edge technology.

With SmartLipo MPX , a hollow, pen-sized instrument called a cannula is inserted into a minor incision made by the surgeon. The cannula uses a small laser to liquefy the fat cells an area and drain them away. Because the cannula is only about 1.0 mm to 2.0 mm, SmartLipo MPX is a less invasive procedure, reducing the risk of bruising and promoting a quicker recovery. In addition, the cannula’s laser acts as a visual guide, helping the surgeon make more precise movements than typical SmartLipo MPX .

With a 1064-nm Nd:YAG laser, the wattage ranges from 6W to 18W, and the higher the wattage allows for a faster procedure. As the laser liquefies fat cells, the laser will simultaneously coagulate small blood vessels, preventing bleeding and swelling. A hollow cannula is also used to suction out the fat cells and speed the recovery process.

Ref: http://www.smartlipompx.com/smartLipo-mpxtechnology.html  

Health & Beauty Updates

  
Researches testing curry's ability to fight cancer

Researchers in the UK are carrying out tests to find out if a chemical found in curry has the ability to fight bowel cancer tumours in patients.

The chemical, Curcumin, which is found in the spice turmeric, is believed to have a range of health benefits. The compound is useful in fighting cancer cells grown in laboratory and it is also beneficial for stroke and dementia patients, according to earlier studies. Researchers at hospitals in Leicester are investigating if giving curcumin alongside chemotherapy drugs will benefit patients. Te4h study will include forty patients at Leicester Royal Infirmary and Leicester General Hospital. The study will study benefits of giving curcumin pills seven days before ard chemotherapy treatment begin for the patients.

The leader of the study, Professor William Steward said, "The prospect that curcumin might increase the sensitivity of cancer cells to chemotherapy is exciting because it could mean giving lower doses, so patients have fewer side effects and can keep having treatment for longer."

He pointed out that the research is at its initial stage but also said that the research might lead to new and more effective drugs in the future for treating the disease.